Mergers & Acquisitions ·
High Court of Justice sanctions Barinthus Biotherapeutics Scheme of Arrangement, trading to halt September 9
BRNSBarinthus Biotherapeutics plc.
Barinthus Biotherapeutics plc announced that the High Court of Justice of England and Wales sanctioned its Scheme of Arrangement on September 1, 2026. The transaction is now expected to become effective on September 9, 2026, triggering a halt in trading for its American Depositary Shares prior to market open on that date. This update reflects a change from the previously disclosed timeline, while plans for delisting and deregistration remain unchanged. Barinthus Biotherapeutics plc operates as a clinical-stage biopharmaceutical company focused on developing treatments for autoimmune diseases.